• Home Abviva receives Japanese patent for Mammastatin Serum Assay Abviva.

Abviva receives Japanese patent for Mammastatin Serum Assay Abviva.

The patents will be the most recent of 13 international and U.S. Patents to concern to the University of Michigan for breast malignancy diagnostic and therapeutic uses of Mammastatin. Not merely will these patent grants enable us to penetrate japan marketplace with proprietary technology, they validate further, along with previous patent grants covering 16 Europe, Canada, Australia, and america, the global patentability of the Mammastatin technology.The American Academy of Pediatrics recommends that toddlers get tested for lead in the bloodstream at 1 and 2 years of age since small children are at risk for lead poisoning if indeed they eat or inhale particles of lead-based paint. High lead levels can cause stomach problems and headaches and also have been associated with some developmental problems also. Liver function check. Liver function tests determine the way the liver is operating and look for any kind of liver damage or inflammation.